Stock 603108 SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Runda Medical Technology Co., Ltd.

Equities

603108

CNE100002318

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
18.16 CNY -5.42% Intraday chart for Shanghai Runda Medical Technology Co., Ltd. +7.01% -10.76%
Apr. 26 Shanghai Runda Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Shanghai Runda Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 7,099 4,167 5,761 6,479 7,772 5,859
Enterprise Value (EV) 1 9,498 6,440 8,044 9,989 12,421 11,591
P/E ratio 32.2 x 16 x 18.8 x 19.6 x 21 x 14.4 x
Yield 0.62% 1.32% - 1.02% - 1.48%
Capitalization / Revenue 1.64 x 0.7 x 0.82 x 0.92 x 0.88 x 0.56 x
EV / Revenue 2.2 x 1.08 x 1.14 x 1.41 x 1.4 x 1.1 x
EV / EBITDA 15 x 6.89 x 7.57 x 9.73 x 10.1 x 9.11 x
EV / FCF -16 x 358 x 105 x -9.56 x -21.9 x -11.4 x
FCF Yield -6.24% 0.28% 0.95% -10.5% -4.57% -8.78%
Price to Book 3.1 x 1.66 x 2.09 x 2.02 x 2.24 x 1.51 x
Nbr of stocks (in thousands) 579,534 579,534 579,534 579,534 579,538 579,543
Reference price 2 12.25 7.190 9.940 11.18 13.41 10.11
Announcement Date 3/28/18 4/23/19 4/29/20 4/26/21 4/26/22 4/25/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 4,319 5,964 7,052 7,069 8,860 10,494
EBITDA 1 634.6 935.3 1,062 1,026 1,227 1,272
EBIT 1 487.2 733.1 831.4 735 949.2 978.5
Operating Margin 11.28% 12.29% 11.79% 10.4% 10.71% 9.32%
Earnings before Tax (EBT) 1 386.7 591.9 685.7 635.8 780.5 819.7
Net income 1 219.2 262 309.5 330 380.2 417.7
Net margin 5.08% 4.39% 4.39% 4.67% 4.29% 3.98%
EPS 2 0.3800 0.4500 0.5300 0.5700 0.6400 0.7000
Free Cash Flow 1 -592.7 17.97 76.32 -1,045 -567.6 -1,018
FCF margin -13.72% 0.3% 1.08% -14.79% -6.41% -9.7%
FCF Conversion (EBITDA) - 1.92% 7.18% - - -
FCF Conversion (Net income) - 6.86% 24.66% - - -
Dividend per Share 2 0.0760 0.0950 - 0.1140 - 0.1500
Announcement Date 3/28/18 4/23/19 4/29/20 4/26/21 4/26/22 4/25/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 2,399 2,273 2,284 3,510 4,649 5,732
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.78 x 2.431 x 2.15 x 3.42 x 3.788 x 4.507 x
Free Cash Flow 1 -593 18 76.3 -1,045 -568 -1,018
ROE (net income / shareholders' equity) 12% 14.7% 15.4% 13.3% 14.1% 13.9%
ROA (Net income/ Total Assets) 5.42% 6.25% 6.27% 4.78% 5.35% 4.61%
Assets 1 4,043 4,193 4,937 6,899 7,112 9,063
Book Value Per Share 2 3.950 4.320 4.760 5.530 5.970 6.710
Cash Flow per Share 2 0.9500 0.6400 1.460 1.440 1.770 1.740
Capex 1 346 264 289 332 301 272
Capex / Sales 8.02% 4.43% 4.09% 4.7% 3.4% 2.59%
Announcement Date 3/28/18 4/23/19 4/29/20 4/26/21 4/26/22 4/25/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD. Stock Shanghai Runda Medical Technology Co., Ltd.
-10.76% 1.5B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.67B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-1.20% 5.26B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+26.10% 5.36B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-53.02% 3.15B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.59B
VITROLIFE AB Stock Vitrolife AB
-14.95% 2.06B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+0.42% 1.74B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 603108 Stock
  4. Financials Shanghai Runda Medical Technology Co., Ltd.